Measurement of a novel biomarker, secretory phospholipase A2 group IIA as a marker of sepsis: A pilot study

Conclusions: sPLA2-IIA shows potential as a biomarker distinguishing sepsis from other disease entities. Further study is warranted to identify predictive value of trends in sPLA-IIA during disease course in septic patients.

Source: Journal of Emergencies, Trauma and Shock - May 29, 2018 Category: Emergency Medicine Authors: Elena Berg Janel Paukovits Jennifer Axelband Jonathan Trager Dina Ryan Kathleen Cichonski Mark Kopnitsky Daniel Zweitzig Rebecca Jeanmonod Source Type: research